TAPENTADOL Pharmacologic Class Indexing
- Class set ID
- b4907728-aaa4-44db-ba88-cef66d39a0a5
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use Tapentadol extended-release tablets safely and effectively. See full prescribing information for tapentadol extended-release tablet Tapentadol extended-release tablet for oral use C-II Initial U.S. Approval: 2008 | Hikma Pharmaceuticals USA Inc. | Collegium Pharmaceutical, Inc. | 20260226 | 3 |
| These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. Tapentadol tablets for oral use C-II Initial U.S. Approval: 2008 | Hikma Pharmaceuticals USA Inc. | Collegium Pharmaceutical, Inc. | 20260226 | 2 |
| These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. TAPENTADOL tablets, for oral use CII Initial U.S. Approval: 2008 | EPIC PHARMA LLC | Humanwell Pharmaceutical US, Inc | 20260128 | 9 |
| These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | Collegium Pharmaceutical, Inc. | Janssen Pharmaceuticals, Inc. | Janssen Ortho, LLC | Patheon Pharmaceuticals, Inc. | 20251230 | 8 |
| These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 2008 | Collegium Pharmaceutical, Inc. | Janssen Pharmaceuticals, Inc. | Halo Pharmaceutical, Inc. d/b/a Cambrex | 20251230 | 7 |
| These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 2008 | Depo NF Sub, LLC | Janssen Pharmaceuticals, Inc. | Janssen Ortho, LLC | 20181207 | 5 |
| These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | Depo NF Sub, LLC | Janssen Pharmaceuticals, Inc. | Janssen Ortho, LLC | 20181022 | 5 |
| These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 2008 | Rebel Distributors Corp | 20110729 | 1 |
| These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 2008 | STAT RX USA LLC | 20100709 | 1 |
| These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 2008 | Physicians Total Care, Inc. | 20100324 | 2 |
| These highlights do not include all the information needed to use NUCYNTA™ safely and effectively. See full prescribing information for NUCYNTA™. NUCYNTA™ (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 2008 | Stat Rx USA | 20091027 | 2 |